What is the treatment for tonsillar pharyngitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Tonsillar Pharyngitis

For confirmed bacterial (Group A Streptococcus) tonsillar pharyngitis, penicillin V or amoxicillin for 10 days remains the first-line treatment, with cephalexin as the preferred second-line option and macrolides reserved only for severe penicillin allergy. 1, 2

Initial Diagnostic Approach

Before initiating antibiotics, confirmation of bacterial etiology is essential:

  • Rapid antigen detection testing (RADT) and/or throat culture should be performed to confirm Group A Streptococcus (GAS) before prescribing antibiotics 1, 2, 3
  • Most tonsillar pharyngitis is viral in origin and does not require antibiotic treatment 1
  • A watchful waiting strategy with symptom relief and no antibiotics is the recommended first-choice approach for suspected viral pharyngitis 1
  • In children, negative RADT results should be confirmed with throat culture, though this may not be necessary in adults given their lower risk of rheumatic fever 1

First-Line Antibiotic Treatment

For confirmed bacterial pharyngitis:

Penicillin Options

  • Penicillin V (phenoxymethylpenicillin): 250 mg 2-3 times daily for children <27 kg; 500 mg 2-3 times daily for children ≥27 kg, adolescents, and adults for 10 days 1, 2
  • Amoxicillin: 50 mg/kg once daily (maximum 1000 mg) for 10 days, or 25 mg/kg twice daily (maximum 500 mg per dose) for 10 days 1, 2
  • Benzathine penicillin G (single intramuscular dose): 600,000 U for patients <27 kg; 1,200,000 U for patients ≥27 kg 1, 2

The 10-day treatment duration is critical to maximize bacterial eradication and prevent rheumatic fever—shorter courses of standard-dose penicillin are less effective 1, 3, 4

Rationale for Penicillin

Penicillin remains the drug of choice because of:

  • Proven efficacy in preventing rheumatic fever (RR 0.27; 95% CI 0.12-0.60) 1
  • Narrow spectrum of activity 1
  • Cost-effectiveness 1
  • No documented GAS resistance to penicillin 1
  • Reduction in suppurative complications including peritonsillar abscess (RR 0.15; 95% CI 0.05-0.47) and acute otitis media (RR 0.30; 95% CI 0.15-0.58) 1

Second-Line Treatment (Penicillin Allergy)

For Non-Anaphylactic Penicillin Allergy

  • Cephalexin (cefalexin): 20 mg/kg/dose twice daily (maximum 500 mg/dose) for 10 days 1, 2, 3
  • Cefadroxil: 30 mg/kg once daily (maximum 1 g) for 10 days 2
  • Cephalosporins show lower rates of clinical relapse compared to penicillin (OR 0.55; 95% CI 0.31-0.99) 1
  • Avoid cephalosporins in patients with immediate (type I) hypersensitivity to penicillin 1

For Severe/Anaphylactic Penicillin Allergy

  • Clindamycin: 20 mg/kg per day divided in 3 doses (maximum 1.8 g/day or 300 mg/dose) for 10 days 1, 2
  • Azithromycin: 12 mg/kg once daily (maximum 500 mg) for 5 days 1, 2, 5
  • Clarithromycin: 15 mg/kg per day divided twice daily (maximum 250 mg twice daily) for 10 days 1, 2

Important Caveats About Macrolides

  • Macrolides should NOT be used as first-line therapy due to increasing resistance rates 1, 6
  • Cephalexin is preferred over macrolides in regions with high macrolide resistance, even for penicillin-allergic patients 1
  • Azithromycin showed no difference compared to penicillin for symptom resolution (OR 1.11; 95% CI 0.92-1.35) but has higher rates of late bacteriological recurrence (OR 1.31; 95% CI 1.16-1.48) 1
  • In clinical trials, azithromycin was clinically and microbiologically superior to penicillin V at Days 14 and 30, with bacteriologic eradication rates of 95% vs 73% at Day 14 5

Treatment of Recurrent or Relapsing Pharyngitis

For patients with documented recurrent GAS pharyngitis or early relapse after appropriate treatment:

  • Clindamycin: 20-30 mg/kg/day in 3 doses (maximum 300 mg/dose) for 10 days 3, 7
  • Amoxicillin-clavulanate: 40 mg amoxicillin/kg/day in 3 doses (maximum 2000 mg amoxicillin/day) for 10 days 3, 7
  • Penicillin V with rifampin: Penicillin V 50 mg/kg/day in 4 doses for 10 days plus rifampin 20 mg/kg/day in 1 dose for the last 4 days 3

Evidence suggests clindamycin and amoxicillin-clavulanate are superior to penicillin for preventing future attacks in patients with recurrent APT, though these studies had moderate risk of bias 7

Common Pitfalls to Avoid

  • Do not prescribe antibiotics without microbiological confirmation of GAS infection—this leads to massive antibiotic overprescribing 1, 3, 8
  • Do not use courses shorter than 10 days for standard penicillin therapy—this increases bacteriologic failure rates from 2-10% to approximately 30% 3, 4
  • Do not use macrolides as first-line therapy when penicillin or cephalosporins are appropriate 1, 6
  • Do not perform routine follow-up throat cultures in asymptomatic patients who completed appropriate therapy 3, 9
  • Do not use sulfonamides, trimethoprim, tetracyclines, or fluoroquinolones for GAS pharyngitis—these are not acceptable alternatives 1

Supportive Care

All patients should receive symptomatic treatment regardless of antibiotic use:

  • NSAIDs (ibuprofen) or acetaminophen for pain and fever 3
  • Warm salt water gargles for patients old enough to perform them 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Treatment for Bacterial Tonsil Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Differentiating Viral from Bacterial Tonsillitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies.

The Pediatric infectious disease journal, 2000

Research

Antibiotics for recurrent acute pharyngo-tonsillitis: systematic review.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018

Research

Group A beta-hemolytic streptococcal infections.

Pediatrics in review, 1998

Guideline

Management of Tonsillitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.